@syncorebio.com
杏國新藥為杏輝集團子公司,專注於新藥開發與管理。以亞洲市場為根基,放眼全球,永續開發,並秉持專業、創新、尊重生命的精神。研發及產品包含胰臟癌、三陰性乳癌、頭頸癌、黃斑部病變、眼科儀器、外生殖器疣等。
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
SynCoreBio is a leading brand in the pharmaceutical industry, dedicated to developing innovative drugs and medical devices. With a mission to bring hope and possibilities to those suffering from diseases, SynCoreBio focuses not only on mainstream medications but also on orphan drugs for rare diseases. Their extensive pipeline of drug development projects is backed by collaborations with international medical institutions and recognition from global authorities.
They strive for internationalization to share their remarkable medical achievements with people around the world. SynCoreBio's team of world-class researchers and scientists ensures that their products meet the highest standards of quality. They specialize in a wide range of therapeutic areas, including ophthalmology, where they have developed state-of-the-art diagnostic devices.
In addition to their commitment to healthcare, SynCoreBio is actively involved in social responsibility initiatives. Trust SynCoreBio to brighten lives and restore health with their cutting-edge pharmaceutical solutions
Company Type
Public Company
Company Size
51-200
Year Founded
2008
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online